These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1822407)

  • 1. Ciclopirox olamine: a hydroxypyridone antifungal agent.
    Abrams BB; Hänel H; Hoehler T
    Clin Dermatol; 1991; 9(4):471-7. PubMed ID: 1822407
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciclopirox: an overview.
    Gupta AK
    Int J Dermatol; 2001 May; 40(5):305-10. PubMed ID: 11554991
    [No Abstract]   [Full Text] [Related]  

  • 3. Ciclopirox for the treatment of superficial fungal infections: a review.
    Gupta AK; Skinner AR
    Int J Dermatol; 2003 Sep; 42 Suppl 1():3-9. PubMed ID: 12895181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
    Jue SG; Dawson GW; Brogden RN
    Drugs; 1985 Apr; 29(4):330-41. PubMed ID: 3158508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
    Weir SJ; Patton L; Castle K; Rajewski L; Kasper J; Schimmer AD
    J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
    Bohn M; Kraemer K
    J Am Podiatr Med Assoc; 2000; 90(10):491-4. PubMed ID: 11107709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses.
    Lassus A; Nolting KS; Savopoulos C
    Clin Ther; 1988; 10(5):594-9. PubMed ID: 2856602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.
    Subissi A; Monti D; Togni G; Mailland F
    Drugs; 2010 Nov; 70(16):2133-52. PubMed ID: 20964457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on effects of ciclopirox olamine on dermatophytosis.
    Zheng YC; Xu TH; Wang SM; Xie JM; Zhu ZR; Yang ZJ
    J Tongji Med Univ; 1987; 7(3):187-90. PubMed ID: 3448247
    [No Abstract]   [Full Text] [Related]  

  • 10. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
    Lee RE; Liu TT; Barker KS; Lee RE; Rogers PD
    J Antimicrob Chemother; 2005 May; 55(5):655-62. PubMed ID: 15814599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclopirox gel: an update.
    Gupta AK
    Int J Dermatol; 2003 Sep; 42 Suppl 1():1-2. PubMed ID: 12895180
    [No Abstract]   [Full Text] [Related]  

  • 12. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.
    Roques C; Brousse S; Panizzutti C
    Mycopathologia; 2006 Dec; 162(6):395-400. PubMed ID: 17146583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties.
    Gupta AK; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():3-8. PubMed ID: 15271193
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis.
    Starova A; Aly R
    Expert Opin Drug Saf; 2005 Mar; 4(2):235-9. PubMed ID: 15794716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase III study of the efficacy and safety of ciclopirox olamine cream in small children with dermatomycosis].
    Gómez-Moyano E; Hiraldo Gamero A; Vera Casaño Á; Crespo Erchiga V; González Enseñat MA; Vicente Villa MA; Zsolt Fradera I; Moreno Giménez JC
    Rev Iberoam Micol; 2015; 32(3):164-9. PubMed ID: 25728876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience in the treatment of skin mycoses with ciclopirox olamine].
    Lecha Carralero V; Martínez Tomás C
    Med Cutan Ibero Lat Am; 1989; 17(1):35-8. PubMed ID: 2666788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopirox olamine: an antifungal alternative against cryptococcosis.
    Oliveira PC; Medeiros CS; Macêdo DP; Andrade SL; Correia MT; Mesquita SD; Lima-Neto RG; Neves RP
    Lett Appl Microbiol; 2010 Nov; 51(5):485-9. PubMed ID: 21039663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis.
    Yu B; Zhou G; Wang B; Ben Y; Yan H; Shao Y; Wang B
    Chin Med Sci J; 1991 Sep; 6(3):166-8. PubMed ID: 1838936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
    Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
    J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.